22 Dec 2020 Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study Member news
16 Dec 2020 Mithra announces positive DSMB safety review and continuation of its Phase III Clinical Program Donesta® in menopause Member news
03 Dec 2020 Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease Member news
01 Dec 2020 Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial Member news
17 Nov 2020 Biocartis announces publication of large multi-center comparison study with Idylla™ MSI Assay showing very low failure rates and excellent concordance with reference methods Member news
20 Oct 2020 Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study Member news
16 Oct 2020 Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients Member news
14 Oct 2020 Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
